Company Filing History:
Years Active: 2025
Title: Richard Duvoux: Innovator in Cardiac Treatment
Introduction
Richard Duvoux is a notable inventor based in Montpellier, France. He has made significant contributions to the field of cardiac treatment through his innovative research and development. His work focuses on novel polymorphic forms of a specific compound that has potential therapeutic applications.
Latest Patents
Richard Duvoux holds a patent for polymorphic forms of (R)-4-(1-((3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl)sulfonyl)-1-fluoroethyl)-N-(isoxazol-3-yl)piperidine-1-carboxamide. This invention provides novel polymorphs that are useful for treating various cardiac disorders, including systolic dysfunction, dilated cardiomyopathy (DCM), and heart failure with preserved ejection fraction (HFrEF). The patent details the synthesis and characterization of these polymorphs, as well as methods for treating heart disease.
Career Highlights
Richard Duvoux is associated with Myokardia, Inc., a company dedicated to developing innovative therapies for heart diseases. His work at Myokardia has been instrumental in advancing treatment options for patients suffering from cardiac conditions.
Collaborations
Richard has collaborated with notable colleagues, including Min Zhong and Olivier Monnier. Their combined expertise has contributed to the success of their research and development efforts.
Conclusion
Richard Duvoux is a prominent inventor whose work in cardiac treatment has the potential to improve the lives of many patients. His innovative approach and dedication to research exemplify the impact of inventors in the medical field.